Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
10/2003
10/07/2003US6630470 G-CSF mimetics
10/07/2003US6630468 Disubstituted pyrazolines and triazolines as factor Xa inhibitors
10/07/2003US6630178 Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of cardiovascular diseases
10/07/2003US6630138 Protein C derivatives
10/07/2003CA2258146C Synthetic polysaccharides, method for preparing same and pharmaceutical compositions containing said polysaccharides
10/07/2003CA1341443C Human c3b/c4b receptor (cr1) (the)
10/05/2003CA2424297A1 Human transferrin for the treatment of anemia of chronic disease (acd) and of functional iron deficiency
10/02/2003WO2003081258A2 Diagnostics and therapeutics for diseases associated with growth hormone secretagogue receptor (ghs)
10/02/2003WO2003081238A2 Cytocapacity test
10/02/2003WO2003080673A1 Costimulatory molecule and its use
10/02/2003WO2003080633A1 Novel $g(a)-amino-n-(diaminophosphinyl)lactam derivative
10/02/2003WO2003080630A2 Phosphate transport inhibitors
10/02/2003WO2003080625A1 Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
10/02/2003WO2003080603A1 Benzodiazepine derivative
10/02/2003WO2003080602A1 Maleic acid salt of (2s)-n-{5-[amino(imino)methyl]-2-thienyl}methyl-1-{(2r)-2-[(carboxymethyl)amino]3,3-diphenylpropanoyl}-2-pyrrolidine carboxamide and a process for
10/02/2003WO2003080601A1 New crystalline forms of (2s)-n-5-[amino(imino)methyl]-2-thienylmethyl-1-(2r)-2-[(carboxymethyl)amino]-3,3-diphenylpropanoyl-2-pyrrolidinecarboxamide nh2o
10/02/2003WO2003080564A1 Menthol substituted antithrombotic pai-1 inhibitors
10/02/2003WO2003080557A1 Substituted 4-aminocyclohexanols
10/02/2003WO2003080553A1 Cyclopentene derivatives
10/02/2003WO2003080181A2 Storage stable eplerenone formulation
10/02/2003WO2003080118A2 Combination of an aldosterone receptor antagonist and a fibric acid derivative
10/02/2003WO2003080108A1 Stable pharmaceutical composition containing factor viii
10/02/2003WO2003080107A1 Remedies for protozoan diseases
10/02/2003WO2003080104A2 Use of il-18 inhibitors for the treatment and/or prevention of peripheral vascular diseases
10/02/2003WO2003080071A1 Novel therapeutical use of agonist ligands specific to g2a receptor
10/02/2003WO2003080068A1 Combination of an aldosterone receptor antagonist and nicotinic acid or a nicotinic acid derivative
10/02/2003WO2003080064A1 Kinase inhibitors
10/02/2003WO2003080062A1 Composition comprising vitamin b9, vitamin b6, lipoic acid and plant extracts for treating circulatory disorders
10/02/2003WO2003080060A1 Substituted piperazine antithrombotic pai-1 inhibitors
10/02/2003WO2003080053A1 Combination treatments for chemokine-mediated diseases
10/02/2003WO2003061379A3 Methods for inactivation of pathogens in biological materials
10/02/2003WO2003045912A8 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
10/02/2003WO2003020767A3 Antibodies against caspase-8, their preparation and use
10/02/2003WO2003010160A3 1-glycinyl-4 (methylpiperidin-4-yl) piperazines and -piperridines as factor xa antagonists
10/02/2003WO2003009779A3 Delivery of therapeutic capable agents
10/02/2003WO2002092759A3 Molecules for disease detection and treatment
10/02/2003WO2002055481A8 Prodrugs of excitatory amino acids
10/02/2003WO2002040047A3 Method for treating thrombocytopenia with monoclonal ivig
10/02/2003WO2002030940A3 Low molecular serine protease inhibitors comprising polyhydroxy-alkyl and polyhydroxy-cycloalkyl radicals
10/02/2003WO2002026781A3 Ige receptor antagonists
10/02/2003WO2002000656A3 Pirazino '1$m(1)2$m(1) :1, 6! pyrido '3,4-b! indole derivatives
10/02/2003WO2001098508A3 Transgenic mice containing targeted gene disruptions
10/02/2003WO2001090155A3 Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses
10/02/2003US20030187302 Enzyme inhibitors, 1-(4-methanesulfonyl-benzylidene)-3,4-dihydro-1H-naphthalene-2 -one oxime
10/02/2003US20030187289 A biphenyl-alkyloxy-benzoylamino-propionic acid or amide derivatives; treating thrombosis, cardiovascular disorders, arteriosclerosis, inflammation, tumor, osteoporosis, angioplasty aftertreatment
10/02/2003US20030187256 Benoxazinones/benzothiazinones as serine protease inhibitors
10/02/2003US20030187226 Process of high purity albumin production
10/02/2003US20030187200 Comprises nucleotide sequences coding kunitz-type protease inhibitor for treating reproductive, hemostatic and inflammatory disorders
10/02/2003US20030187060 Aminoalkenylbenzoyl-benzofuran or benzothiophene, method for preparing same and compositions containing same
10/02/2003US20030187038 Fibrinogen-lowering agents
10/02/2003US20030187037 Cardiovascular disorders; antiinflammatory agents; antitumor agents
10/02/2003US20030187032 Pharmaceutical compositions comprising 1-isopropyl-3-[(4-m-toluidino-3-pyridyl)sulphonyl]-urea as active ingredient
10/02/2003US20030187024 Vision disorders; antiinflammatory agents; autoimmune disease; anticancer qgents; skin disorders
10/02/2003US20030187023 Sulfone derivatives, process for their production and use thereof
10/02/2003US20030187007 Inhibitors of protein kinase for the treatment of disease
10/02/2003US20030186989 Antihistamines; respiratory system disorders
10/02/2003US20030186981 Antiinflammatory agents; osteoporosis; rheumatic diseases; autoimmune diseases
10/02/2003US20030186976 Benzofurylpyrone derivatives
10/02/2003US20030186974 Pyrrolyl- and imidazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes
10/02/2003US20030186970 Androgen receptor modulator compounds and methods
10/02/2003US20030186969 Benzodiazepine derivatives
10/02/2003US20030186966 Antiinflammatory agents; autoimmune disease; antiallergens
10/02/2003US20030186964 Piperdines for use as orexin receptor antagonists
10/02/2003US20030186896 Crystalline form of perindopril tert-butylamine salt
10/02/2003US20030186894 Dry powder compositions having improved dispersivity
10/02/2003US20030186885 Soluble polypeptides comprising extracellular domains or variable peptides of blood coagulation factors, used for immunotherapy or for prophylaxis of thrombosis and cardiovascular disorders
10/02/2003US20030186883 Glycoprotein mimetics having ability for potentiation of thrombin-mediated activation of protein C and inability to activate thrombin-activatable fibrinolysis inhibitor (TAFI), used as anticoagulants
10/02/2003US20030186865 Pharmaceutical combination for the treatment of tissue damage owing to an arterial irrigation defect
10/02/2003US20030186842 Contacting a cell population with an inhibiting effective amount of a reagent that suppresses the protease activity of at least one member of the interleukin-1beta- converting enzyme (ICE)/CED-3 family
10/02/2003US20030186422 Methods for the treatment of thrombosis
10/02/2003US20030186337 Novel death associated proteins, and THAP1 and PAR4 pathways in apoptosis control
10/02/2003US20030186308 Prostacyclin-stimulating factor-2
10/02/2003US20030186264 Comprises enzymatic polypeptide for diagnosis and treatment of genetic disorders; drug screening; immunoassay; high throughput assay
10/02/2003US20030185909 Composition of traditional chinese medicines for preventing and treating cerebrovascular disease
10/02/2003US20030185890 Compositions and methods for polynucleotide delivery
10/02/2003US20030185819 Treatment of specific and non-specific inflammation, including asthma; useful in diagnosing and localizing sites of inflammation.
10/02/2003US20030185818 Humanized antibody against cd18
10/02/2003US20030185816 Modified immunogenic self-protein and a surfactant capable of acting as a solubiliser, especially modified human TNF alpha and cetylpyridinium chloride
10/02/2003US20030185815 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
10/02/2003US20030185791 TNF-derived peptides for use in treating oedema
10/02/2003US20030185758 Embolizing a blood vessel by injecting a mixture os polyacrylonitrile, polyvinyl acetate, cellulose acetate butyrate, nitrocellulose, polycarbonate urethane or maleic acid-styrene copolymer; contrast agent and solvent
10/02/2003CA2479898A1 Novel .alpha.-amino-n-(diaminophosphinyl)lactam derivatives
10/02/2003CA2479893A1 Maleic acid salt of (2s)-n-{5-¬amino(imino)methyl|-2-thienyl}methyl-1-{(2r)-2-¬(carboxymethyl)amino|3,3-diphenylpropanoyl}-2-pyrrolidine carboxamide and a process for preparing the same
10/02/2003CA2479888A1 New crystalline forms of (2s)-n-5-¬amino(imino)methyl|-2-thienylmethyl-1-(2r)-2-¬(carboxymethyl)amino|-3,3-diphenylpropanoyl-2-pyrrolidinecarboxamide nh2o
10/02/2003CA2479722A1 Combination of an aldosterone receptor antagonist and a fibric acid derivative
10/02/2003CA2479671A1 Combination of an aldosterone receptor antagonist and nicotinic acid for a nicotinic acid derivative
10/02/2003CA2479383A1 Storage stable eplerenone formulation
10/02/2003CA2478855A1 Use of il-18 inhibitors for the treatment and/or prevention of peripheral vascular diseases
10/02/2003CA2477651A1 Kinase inhibitors
10/01/2003EP1348710A1 Sulfonamide derivatives of 3-substituted imidazo[1,2-D]-1,2,4-thiadiazoles and 3-substituted-[1,2,4]thiadiazolo[4,5-A]benzimidazole as inhibitors of fibrin cross-linking and transglutaminases
10/01/2003EP1348435A1 Preparation process of pure form (II) 1-isopropyl-3-[(4-M toluidino-3-pyridyl) sulphonyl]-urea (Torasemide) and pharmaceutical preparations thereof
10/01/2003EP1348026A2 Fibrin binding moieties useful as imaging agents
10/01/2003EP1347981A1 Condensed purine derivatives as a 1? adenosine receptor antagonists
10/01/2003EP1347980A1 Compounds specific to adenosine-a1,-a2a, and- a3-receptor and uses thereof
10/01/2003EP1347979A1 Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands
10/01/2003EP1347972A1 Pyrazolo 3,4-c]pyridines as gsk-3 inhibitors
10/01/2003EP1347955A1 New mandelic acid derivatives and their use as throbin inhibitors
10/01/2003EP1347805A2 Pharmaceutical preparation for douches and/or irrigations of natural or pathological cavities in the human body
10/01/2003EP1347780A1 Compositions of n-(methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridylsulfonamide and cyclic oligosaccharides
10/01/2003EP1347762A2 Pharmaceutical formulation containing thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives (2)
1 ... 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 ... 671